Format
Sort by
Items per page

Send to

Choose Destination

Best matches for anza1 schizophrenia:

Evolving Notions of Schizophrenia as a Developmental Neurocognitive Disorder. Seidman LJ et al. J Int Neuropsychol Soc. (2017)

The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum. Guloksuz S et al. Psychol Med. (2018)

Rethinking schizophrenia. Insel TR et al. Nature. (2010)

Search results

Items: 1 to 20 of 136104

  • The following term was not found in PubMed: anza1.
1.

Psychometric liability to psychosis and childhood adversities are associated with shorter telomere length: A study on schizophrenia patients, unaffected siblings, and non-clinical controls.

Çevik B, Mançe-Çalışır Ö, Atbaşoğlu EC, Saka MC, Alptekin K, Üçok A, Sırmatel B, Gülöksüz S, Tükün A, van Os J, Gümüş-Akay G.

J Psychiatr Res. 2019 Feb 8;111:169-185. doi: 10.1016/j.jpsychires.2019.01.022. [Epub ahead of print]

PMID:
30776705
2.

Trends in concept and nosology of autism spectrum disorder: A review.

Gyawali S, Patra BN.

Asian J Psychiatr. 2019 Feb 10;40:92-99. doi: 10.1016/j.ajp.2019.01.021. [Epub ahead of print] Review.

PMID:
30776666
3.

Antipsychotic-minocycline-acetylcysteine combination for positive, cognitive, and negative symptoms of schizophrenia.

Koola MM.

Asian J Psychiatr. 2019 Feb 12;40:100-102. doi: 10.1016/j.ajp.2019.02.007. [Epub ahead of print]

PMID:
30776665
4.

A meta-analysis and systematic review of Memory Specificity Training (MeST) in the treatment of emotional disorders.

Barry TJ, Sze WY, Raes F.

Behav Res Ther. 2019 Feb 2;116:36-51. doi: 10.1016/j.brat.2019.02.001. [Epub ahead of print]

PMID:
30776658
5.

Rhodiola rosea root extract has antipsychotic-like effects in rodent models of sensorimotor gating.

Coors A, Brosch M, Kahl E, Khalil R, Michels B, Laub A, Franke K, Gerber B, Fendt M.

J Ethnopharmacol. 2019 Feb 15. pii: S0378-8741(18)33766-8. doi: 10.1016/j.jep.2019.02.031. [Epub ahead of print]

PMID:
30776471
6.

An examination of the moderating effects of neurophysiology on treatment outcomes from cognitive training in schizophrenia-spectrum disorders.

Best MW, Milanovic M, Shamblaw AL, Muere A, Lambe LJ, Hong IK, Haque MK, Bowie CR.

Int J Psychophysiol. 2019 Feb 15. pii: S0167-8760(18)30863-8. doi: 10.1016/j.ijpsycho.2019.02.004. [Epub ahead of print]

PMID:
30776393
7.

Heritability of Cerebral Blood Flow and the Correlation to Schizophrenia Spectrum Disorders: A Pseudo-continuous Arterial Spin Labeling Twin Study.

Legind CS, Broberg BV, Brouwer R, Mandl RCW, Ebdrup BH, Anhøj SJ, Jensen MH, Hilker R, Fagerlund B, Hulshoff Pol HE, Glenthøj BY, Rostrup E.

Schizophr Bull. 2019 Feb 18. pii: sbz007. doi: 10.1093/schbul/sbz007. [Epub ahead of print]

PMID:
30776063
8.

The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice.

Zheng P, Zeng B, Liu M, Chen J, Pan J, Han Y, Liu Y, Cheng K, Zhou C, Wang H, Zhou X, Gui S, Perry SW, Wong ML, Licinio J, Wei H, Xie P.

Sci Adv. 2019 Feb 6;5(2):eaau8317. doi: 10.1126/sciadv.aau8317. eCollection 2019 Feb.

PMID:
30775438
9.

A novel approach to cardiovascular disturbances in patients with schizophrenia spectrum disorders treated with long-acting injectable medication.

Andor M, Dehelean L, Romosan AM, Buda V, Radu G, Caruntu F, Bordejevic A, Manea MM, Papava I, Bredicean CA, Romosan RS, Tomescu M.

Neuropsychiatr Dis Treat. 2019 Jan 25;15:349-355. doi: 10.2147/NDT.S186892. eCollection 2019.

10.

Cognition and physical functioning in patients with schizophrenia: any role for vitamin D?

Zoghbi M, Haddad C, Hallit S, Nabout R, Medlej-Hashim M, Hachem D, Azar J.

Nutr Neurosci. 2019 Feb 17:1-9. doi: 10.1080/1028415X.2019.1580830. [Epub ahead of print]

PMID:
30774039
11.

Assessment of 3-dimensional wisdom in schizophrenia: Associations with neuropsychological functions and physical and mental health.

Van Patten R, Lee EE, Daly R, Twamley E, Tu XM, Jeste DV.

Schizophr Res. 2019 Feb 11. pii: S0920-9964(19)30026-X. doi: 10.1016/j.schres.2019.01.022. [Epub ahead of print]

PMID:
30773419
12.

Distinct temporal brain dynamics in bipolar disorder and schizophrenia during emotion regulation.

Zhang L, Ai H, Opmeer EM, Marsman JC, van der Meer L, Ruhé HG, Aleman A, van Tol MJ.

Psychol Med. 2019 Feb 18:1-9. doi: 10.1017/S0033291719000217. [Epub ahead of print]

PMID:
30773147
13.

The subjective-objective deficit paradox in schizotypy extends to emotion regulation and awareness.

Li LY, Karcher NR, Kerns JG, Fung CK, Martin EA.

J Psychiatr Res. 2019 Jan 31;111:160-168. doi: 10.1016/j.jpsychires.2019.01.026. [Epub ahead of print]

PMID:
30772760
14.

Real-world effectiveness of antipsychotic monotherapy and polytherapy in 1543 patients with acute-phase schizophrenia.

Hatta K, Hasegawa H, Imai A, Sudo Y, Morikawa F, Katayama S, Watanabe H, Ishizuka T, Nakamura M, Misawa F, Fujita K, Ozaki S, Umeda K, Nakamura H, Sawa Y, Sugiyama N; JAST study group.

Asian J Psychiatr. 2019 Feb 8;40:82-87. doi: 10.1016/j.ajp.2019.02.005. [Epub ahead of print]

PMID:
30772732
15.

Effects of sodium nitroprusside in the acute dizocilpine (MK-801) animal model of schizophrenia.

Wang X, Ding S, Lu Y, Jiao Z, Zhang L, Zhang Y, Yang Y, Zhang Y, Li W, Lv L.

Brain Res Bull. 2019 Feb 14. pii: S0361-9230(18)30692-0. doi: 10.1016/j.brainresbull.2019.02.008. [Epub ahead of print]

16.

The antipsychotic-like effects of clozapine in C57BL/6 mice exposed to cuprizone: decreased glial activation.

Chang H, Wei Y, Du L, Cong H, Geng X, Yin L.

Behav Brain Res. 2019 Feb 14. pii: S0166-4328(18)31295-6. doi: 10.1016/j.bbr.2019.02.026. [Epub ahead of print]

PMID:
30772428
17.

Genome-Scale Transcriptional Regulatory Network Models of Psychiatric and Neurodegenerative Disorders.

Pearl JR, Colantuoni C, Bergey DE, Funk CC, Shannon P, Basu B, Casella AM, Oshone RT, Hood L, Price ND, Ament SA.

Cell Syst. 2019 Jan 31. pii: S2405-4712(19)30030-4. doi: 10.1016/j.cels.2019.01.002. [Epub ahead of print]

PMID:
30772379
18.

Altered dynamic global signal topography in antipsychotic-naive adolescents with early-onset schizophrenia.

Wang X, Liao W, Han S, Li J, Zhang Y, Zhao J, Chen H.

Schizophr Res. 2019 Feb 14. pii: S0920-9964(19)30038-6. doi: 10.1016/j.schres.2019.01.035. [Epub ahead of print]

PMID:
30772067
19.

Patterns of recovery course in early intervention for FIRST episode non-affective psychosis patients: The role of timing.

Ayesa-Arriola R, Pelayo Terán JM, Setién-Suero E, Neergaard K, Ochoa S, Ramírez-Bonilla M, Pérez-Iglesias R, Crespo-Facorro B.

Schizophr Res. 2019 Feb 14. pii: S0920-9964(19)30030-1. doi: 10.1016/j.schres.2019.01.032. [Epub ahead of print]

PMID:
30772066
20.

The Vitamins in Psychosis Study: A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Vitamins B12, B6, and Folic Acid on Symptoms and Neurocognition in First-Episode Psychosis.

Allott K, McGorry PD, Yuen HP, Firth J, Proffitt TM, Berger G, Maruff P, O'Regan MK, Papas A, Stephens TCB, O'Donnell CP.

Biol Psychiatry. 2019 Jan 9. pii: S0006-3223(19)30001-0. doi: 10.1016/j.biopsych.2018.12.018. [Epub ahead of print]

PMID:
30771856

Supplemental Content

Loading ...
Support Center